세계의 시스타틴 C 측정 시장 규모 조사 및 예측 : 제품 유형별, 측정법별, 샘플 유형별, 용도별, 최종 사용자별, 지역별 분석(2023-2030년)

Global Cystatin C Assay Market is valued at approximately USD 350.70 million in 2022 and is anticipated to grow with a healthy growth rate of more than 7.5% during the forecast period 2023-2030. The Cystatin C assay is a diagnostic test that measures the levels of cystatin C in the blood, a protein produced by cells and filtered through the kidneys. Cystatin C is less affected by age and muscle mass compared to conventional kidney function measures. This test is useful for monitoring kidney disorders, determining the glomerular filtration rate, and evaluating renal function. It offers vital information about general renal health and is used by medical practitioners to inform treatment choices and assess the risk of issues connected to the kidneys. The increasing prevalence of kidney diseases, supportive government policies, surge in healthcare expenditure, as well as flourishing growth of the biotechnology and biopharmaceutical industries, are the most prominent factors that are bolstering the market demand across the globe.

Additionally, the growing incidences of chronic kidney diseases are expected to boost the Cystatin C Assay Market. A 2022 report from the Centers for Disease Control and Prevention (CDC) reveals that over 14% of U.S. adults, approximately 37 million individuals, suffer from CKD. Consequently, with the rising prevalence of chronic kidney diseases worldwide, there is an increasing demand for reliable diagnostic solutions to measure cystatin C concentration, thereby propelling market expansion. Also, the growing geriatric population base is further presenting various growth prospects for market expansion as they are more prone to be affected by the CKD and various chronic diseases due to their weak immune system. As per the United Nations, there were 703 million persons aged 65 years or over in the world in 2019. The figure for aged persons is projected to get double and reach 1.5 billion by 2050. Thereby, the demand for cystatin C assays is expected to increase as the growing incidences of chronic kidney diseases, along with the global population age. Moreover, the increasing adoption of point of care testing, as well as the rising focus on the development of condition-specific biomarkers and tests presents various lucrative opportunities over the forecast years. However, the high development costs of cystatin C assays and stringent requirements for approval of cystatin C assay instruments and consumables are hindering market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Cystatin C Assay Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the stringent regulatory standards, an increasing trend in healthcare expenditure, the growing prevalence of chronic kidney diseases, the increasing elderly population, and the high presence of manufacturers specializing in cystatin C assays. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The surge in health awareness, escalating healthcare spending, the growth of medical tourism, and the expanding geriatric demographic are significantly propelling the market demand across the region. The rise in the elderly population is associated with a higher incidence of nephros diseases. Consequently, the increase in kidney diseases leading to the expansion of this demographic is directly stimulating the demand for cystatin C assay products. This, in turn, is fostering growing research and development activities and strategic initiatives by key industry players.

Major market players included in this report are:

• Abbott (US)
• Roche Diagnostics Limited (Switzerland)
• Siemens Healthineers AG (Germany)
• Thermo Fisher Scientific Inc. (US)
• Randox Laboratories Ltd. (UK)
• DiaSys Diagnostic Systems GmbH (Germany)
• Bio-Techne (US)
• Gentian Diagnostics ASA (Norway)
• Getein Biotech, Inc. (China)
• Agilent Technologies, Inc. (US)

Recent Developments in the Market:

• In March 2021, Roche completed the acquisition of GenMark Diagnostics, purchasing each share for USD 24.05 and achieving a total transaction value of USD 1.8 billion. This strategic move significantly bolstered Roche's Diagnostics portfolio.
• In March 2022, Gentian- a leading participant in the cystatin C test industry announced that TuV SUD has validated their GCAL and Cystatin C assays for IVDR (In-Vitro Diagnostic Regulation). The assays meet the regulatory requirements outlined by IVDR, as indicated by this certification. This strategic introduction aimed to increase income and broaden its services.

Global Cystatin C Assay Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Product, Method, Sample Type, Application, End-user, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

• Analyzers
• Kits
• Reagents

By Method:

• Enzyme-Linked Immunosorbent Assay (ELISA)
• Particle-Enhanced Turbidimetric Immunoassay (PETIA)
• Particle-enhanced Nephelometric Immunoassay (PENIA)
• Chemiluminescent immunoassay (CLIA)
• Immunofluorescence assay (IFA)
• Others

By Sample Type:

• Blood
• Urine

By Application:

• Diagnostics
• Research

By End-user:

• Hospitals
• Clinical Laboratories
• Pharmaceutical and Biotechnology Companies & CROs & Academic research institutes

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
  • 1.2.1. Cystatin C Assay Market, by Region, 2020-2030 (USD Million)
  • 1.2.2. Cystatin C Assay Market, by Product, 2020-2030 (USD Million)
  • 1.2.3. Cystatin C Assay Market, by Method, 2020-2030 (USD Million)
  • 1.2.4. Cystatin C Assay Market, by Sample Type, 2020-2030 (USD Million)
  • 1.2.5. Cystatin C Assay Market, by Application, 2020-2030 (USD Million)
  • 1.2.6. Cystatin C Assay Market, by End-user, 2020-2030 (USD Million)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Cystatin C Assay Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Cystatin C Assay Market Dynamics

• 3.1. Cystatin C Assay Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Supportive government policies
    • 3.1.1.2. Rising incidences of chronic kidney diseases and increasing aging population
  • 3.1.2. Market Challenges
    • 3.1.2.1. High development costs of cystatin C assays
    • 3.1.2.2. Stringent requirements for approval of cystatin C assay instruments and consumables
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Increasing adoption of point of care testing
    • 3.1.3.2. Rising focus on the development of condition-specific biomarkers and tests

Chapter 4. Global Cystatin C Assay Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Cystatin C Assay Market, by Product

• 5.1. Market Snapshot
• 5.2. Global Cystatin C Assay Market by Product, Performance - Potential Analysis
• 5.3. Global Cystatin C Assay Market Estimates & Forecasts by Product 2020-2030 (USD Million)
• 5.4. Cystatin C Assay Market, Sub Segment Analysis
  • 5.4.1. Analyzers
  • 5.4.2. Kits
  • 5.4.3. Reagents

Chapter 6. Global Cystatin C Assay Market, by Method

• 6.1. Market Snapshot
• 6.2. Global Cystatin C Assay Market by Method, Performance - Potential Analysis
• 6.3. Global Cystatin C Assay Market Estimates & Forecasts by Method 2020-2030 (USD Million)
• 6.4. Cystatin C Assay Market, Sub Segment Analysis
  • 6.4.1. Enzyme-Linked Immunosorbent Assay (ELISA)
  • 6.4.2. Particle-Enhanced Turbidimetric Immunoassay (PETIA)
  • 6.4.3. Particle-enhanced Nephelometric Immunoassay (PENIA)
  • 6.4.4. Chemiluminescent immunoassay (CLIA)
  • 6.4.5. Immunofluorescence assay (IFA)
  • 6.4.6. Others

Chapter 7. Global Cystatin C Assay Market, by Sample Type

• 7.1. Market Snapshot
• 7.2. Global Cystatin C Assay Market by Sample Type, Performance - Potential Analysis
• 7.3. Global Cystatin C Assay Market Estimates & Forecasts by Sample Type 2020-2030 (USD Million)
• 7.4. Cystatin C Assay Market, Sub Segment Analysis
  • 7.4.1. Blood
  • 7.4.2. Urine

Chapter 8. Global Cystatin C Assay Market, by Application

• 8.1. Market Snapshot
• 8.2. Global Cystatin C Assay Market by Application, Performance - Potential Analysis
• 8.3. Global Cystatin C Assay Market Estimates & Forecasts by Application 2020-2030 (USD Million)
• 8.4. Cystatin C Assay Market, Sub Segment Analysis
  • 8.4.1. Diagnostics
  • 8.4.2. Research

Chapter 9. Cystatin C Assay Market, by End-user

• 9.1. Market Snapshot
• 9.2. Global Cystatin C Assay Market by End-user, Performance - Potential Analysis
• 9.3. Global Cystatin C Assay Market Estimates & Forecasts by End-user 2020-2030 (USD Million)
• 9.4. Cystatin C Assay Market, Sub Segment Analysis
  • 9.4.1. Hospitals
  • 9.4.2. Clinical Laboratories
  • 9.4.3. Pharmaceutical and Biotechnology Companies & CROs & Academic research institutes

Chapter 10. Global Cystatin C Assay Market, Regional Analysis

• 10.1. Top Leading Countries
• 10.2. Top Emerging Countries
• 10.3. Cystatin C Assay Market, Regional Market Snapshot
• 10.4. North America Cystatin C Assay Market
  • 10.4.1. U.S. Cystatin C Assay Market
    • 10.4.1.1. Product breakdown estimates & forecasts, 2020-2030
    • 10.4.1.2. Method breakdown estimates & forecasts, 2020-2030
    • 10.4.1.3. Sample Type breakdown estimates & forecasts, 2020-2030
    • 10.4.1.4. Application breakdown estimates & forecasts, 2020-2030
    • 10.4.1.5. End-user breakdown estimates & forecasts, 2020-2030
  • 10.4.2. Canada Cystatin C Assay Market
• 10.5. Europe Cystatin C Assay Market Snapshot
  • 10.5.1. U.K. Cystatin C Assay Market
  • 10.5.2. Germany Cystatin C Assay Market
  • 10.5.3. France Cystatin C Assay Market
  • 10.5.4. Spain Cystatin C Assay Market
  • 10.5.5. Italy Cystatin C Assay Market
  • 10.5.6. Rest of Europe Cystatin C Assay Market
• 10.6. Asia-Pacific Cystatin C Assay Market Snapshot
  • 10.6.1. China Cystatin C Assay Market
  • 10.6.2. India Cystatin C Assay Market
  • 10.6.3. Japan Cystatin C Assay Market
  • 10.6.4. Australia Cystatin C Assay Market
  • 10.6.5. South Korea Cystatin C Assay Market
  • 10.6.6. Rest of Asia Pacific Cystatin C Assay Market
• 10.7. Latin America Cystatin C Assay Market Snapshot
  • 10.7.1. Brazil Cystatin C Assay Market
  • 10.7.2. Mexico Cystatin C Assay Market
• 10.8. Middle East & Africa Cystatin C Assay Market
  • 10.8.1. Saudi Arabia Cystatin C Assay Market
  • 10.8.2. South Africa Cystatin C Assay Market
  • 10.8.3. Rest of Middle East & Africa Cystatin C Assay Market

Chapter 11. Competitive Intelligence

• 11.1. Key Company SWOT Analysis
  • 11.1.1. Company 1
  • 11.1.2. Company 2
  • 11.1.3. Company 3
• 11.2. Top Market Strategies
• 11.3. Company Profiles
  • 11.3.1. Abbott (US)
    • 11.3.1.1. Key Information
    • 11.3.1.2. Overview
    • 11.3.1.3. Financial (Subject to Data Availability)
    • 11.3.1.4. Product Summary
    • 11.3.1.5. Recent Developments
  • 11.3.2. Roche Diagnostics Limited (Switzerland)
  • 11.3.3. Siemens Healthineers AG(Germany)
  • 11.3.4. Thermo Fisher Scientific Inc. (US)
  • 11.3.5. Randox Laboratories Ltd. (UK)
  • 11.3.6. DiaSys Diagnostic Systems GmbH (Germany)
  • 11.3.7. Bio-Techne (US)
  • 11.3.8. Gentian Diagnostics ASA (Norway)
  • 11.3.9. Getein Biotech, Inc. (China)
  • 11.3.10. Agilent Technologies, Inc. (US)

Chapter 12. Research Process

• 12.1. Research Process
  • 12.1.1. Data Mining
  • 12.1.2. Analysis
  • 12.1.3. Market Estimation
  • 12.1.4. Validation
  • 12.1.5. Publishing
• 12.2. Research Attributes
• 12.3. Research Assumption